News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lantheus Medical Imaging Launches DEFINITY(R) Ultrasound Contrast Imaging Agent in India


7/15/2010 9:00:23 AM

N. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the launch of its ultrasound contrast imaging agent, DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, in India. The company has signed a multi-year agreement with Mumbai-based J.B. Chemicals & Pharmaceuticals, Ltd. (“JBCPL”) for the distribution and marketing of DEFINITY® in the Indian marketplace. The launch expands Lantheus’ presence in southern Asia. DEFINITY® is currently marketed in North America, Australia and New Zealand, parts of the Pacific Rim, and several countries in the Middle East.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES